Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Mitomics, Sterling Pathology National Laboratories; J. Craig Venter Institute, CLC Bio; LabCorp

NEW YORK (GenomeWeb News) – Mitomics said this week it has entered into a sales and marketing deal with Sterling Pathology National Laboratories covering Mitomics' Prostate Core Mitomic Test. Sterling will make the test available throughout the US on a non-exclusive basis. Further terms were not disclosed.


The J. Craig Venter Institute has extended its site license agreement with CLC Bio through 2017. JCVI has used CLC Bio's enterprise platform since 2009 including for its work as part of the Human Microbiome Project.


Laboratory Corporation of America Holdings said its Biorepository has been accredited by the College of American Pathologists. LabCorp opened the Biorepository in 2009 and offers well-annotated, consented specimens for biomarker discovery research.


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.